Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04577976 · ClinicalTrials.gov registry record
FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pediatric Patients - BG
A clinical trial, sponsored by Abbott Diabetes Care.
- Terminated
- Registry status
- 62
- Enrollment target
NCT04577976 is a clinical trial that was terminated before completion, run by Abbott Diabetes Care. The registered enrollment target is 62 participants.
The verdict
NCT04577976 was terminated before completion, sponsored by Abbott Diabetes Care.
- TERMINATED
- Registry status
- 62 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, non-randomized, single-arm study intended to characterize the safety of self-monitoring of blood glucose (SMBG) when used to manage diabetes in pediatric patients.
Interventions
- DEVICE SMBG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2020-09-23 |
| Est. Completion | 2022-07-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04577976
The ClinicalTrials.gov registry entry for NCT04577976 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Diabetes Care, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SMBG is the first listed.
NCT04577976 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04577976 about?
NCT04577976 is a clinical study titled "FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pediatric Patients - BG". This is a prospective, multi-center, non-randomized, single-arm study intended to characterize the safety of self-monitoring of blood glucose (SMBG) when used to manage diabetes in pediatric patients.
What is the current status of trial NCT04577976?
This trial is currently terminated. The enrollment target is 62 participants. The study started on 2020-09-23. Estimated completion is 2022-07-14.
What interventions are being tested in trial NCT04577976?
The interventions under investigation include: SMBG (DEVICE).
Who is sponsoring clinical trial NCT04577976?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.